- Home
- EWBC vs ASND Comparison
EWBC vs ASND Comparison
Compare EWBC & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EWBC
- ASND
- Stock Information
- Founded
- EWBC 1998
- ASND 2006
- Country
- EWBC United States
- ASND Denmark
- Employees
- EWBC N/A
- ASND N/A
- Industry
- EWBC Major Banks
- ASND Biotechnology: Pharmaceutical Preparations
- Sector
- EWBC Finance
- ASND Health Care
- Exchange
- EWBC Nasdaq
- ASND Nasdaq
- Market Cap
- EWBC 9.9B
- ASND 9.1B
- IPO Year
- EWBC 1999
- ASND 2015
- Fundamental
- Price
- EWBC $77.43
- ASND $165.05
- Analyst Decision
- EWBC Buy
- ASND Strong Buy
- Analyst Count
- EWBC 13
- ASND 15
- Target Price
- EWBC $106.46
- ASND $202.00
- AVG Volume (30 Days)
- EWBC 1.6M
- ASND 506.0K
- Earning Date
- EWBC 04-22-2025
- ASND 05-01-2025
- Dividend Yield
- EWBC 3.10%
- ASND N/A
- EPS Growth
- EWBC 1.83
- ASND N/A
- EPS
- EWBC 8.33
- ASND N/A
- Revenue
- EWBC $2,385,692,000.00
- ASND $376,478,932.00
- Revenue This Year
- EWBC $5.34
- ASND $61.43
- Revenue Next Year
- EWBC $7.00
- ASND $73.07
- P/E Ratio
- EWBC $9.30
- ASND N/A
- Revenue Growth
- EWBC 0.99
- ASND 36.34
- 52 Week Low
- EWBC $68.27
- ASND $111.09
- 52 Week High
- EWBC $113.95
- ASND $169.37
- Technical
- Relative Strength Index (RSI)
- EWBC 42.16
- ASND 62.95
- Support Level
- EWBC $68.27
- ASND $152.07
- Resistance Level
- EWBC $77.25
- ASND $159.14
- Average True Range (ATR)
- EWBC 5.17
- ASND 10.95
- MACD
- EWBC -0.04
- ASND 1.28
- Stochastic Oscillator
- EWBC 36.68
- ASND 99.11
About EWBC East West Bancorp Inc.
East West Bancorp Inc operates in U.S. and Asia. The Bank provides range of personal and commercial banking services to individuals and businesses. In addition to offering traditional deposit products that include personal and business checking and savings accounts, money market, and time deposits, the Bank also offers foreign exchange, treasury management and wealth management services. The Bank has three operating segments, (1) Consumer and Business Banking, (2) Commercial Banking and (3) Treasury and Other. The company generates the majority of its revenue from the Commercial banking segment.
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.